Fig. 4: RNA editing and time to first treatment.
From: RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia
a Time to first treatment is shown for time from sampling (left graph) and time from diagnosis (right graph) for IGHV mutated (a) and IGHV unmutated samples (b) from the Ferreira cohort [20]. Univariate analyses for cluster 1 versus noncluster 1 patients are indicated in graphs. c Multivariate analysis of time to first treatment from sampling and diagnosis of IGHV mutated patients according to the indicated risk parameters. (TTFT time to first treatment, HR Hazard Ratio CI confidence interval, p: significance).
